Eli Lilly LLY Other accrued liabilities
Other accrued liabilities at other companies
Other financials
Where this comes from
Reported directly by Eli Lilly in its filing.
Tagged under the XBRL concept us-gaap:OtherLiabilitiesCurrent.
The official record: Eli Lilly’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Eli Lilly's other accrued liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Eli Lilly's other accrued liabilities?
- Eli Lilly (LLY) reported other accrued liabilities of $8.7B in Q1 2026.
- How has Eli Lilly's other accrued liabilities changed year-over-year?
- Eli Lilly's other accrued liabilities increased by 130.8% year-over-year, from $3.77B to $8.7B.
- What is the long-term trend for Eli Lilly's other accrued liabilities?
- Over 5 years (2020 to 2025), Eli Lilly's other accrued liabilities has grown at a 25.2% compound annual growth rate (CAGR), from $2.75B to $8.46B.